Introduction of pharmaceutical expertise in a palliative care team in Sweden

Norrström, Barbro; Cannerfelt, Ing-Britt; Frid, Helen; Roos, Kim Caroline; Ramström, Helena

doi:10.1007/s11096-010-9450-5

Cited by 14 publications

(18 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…3 Reports have been published that describe the role of a pharmacist in palliative care and provide pilot data on evaluating the benefit and effectiveness of services offered. [4][5][6][7][8] However, no report was identified from a center in the Middle East or Gulf Cooperation Council (GCC). The GCC is a political and economic union of Arab states bordering the Persian Gulf, namely, Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates.…”

Section: Introductionmentioning

confidence: 99%

Evaluation of Clinical Pharmacy Services Offered for Palliative Care Patients in Qatar

Wilby

Mohamad²,

Alyafei³

2014

Journal of Pain & Palliative Care Pharmacotherapy

View full text Add to dashboard Cite

Palliative care is an emerging concept in the countries of the Gulf Cooperation Council, a political and economic union of Arab states bordering the Persian Gulf, namely Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates. Clinical pharmacy services have not yet been evaluated in this region. The objectives of this study were to create a baseline inventory of clinical pharmacy interventions in palliative care and to assess the perceived importance of interventions made. This was a prospective, single-center characterization study. Interventions were documented from September 30 to December 1, 2013. They were characterized into predetermined categories and analyzed using descriptive statistics. Physician acceptance rate and intervention rate per patient were calculated. Classification categories were sent to 10 practicing pharmacists in each of Qatar and Canada, who ranked the categories on the basis of perceived importance. A total of 96 interventions were documented, giving 3 interventions per patient and an acceptance rate of 81%. Discontinuing therapy (29%), initiating therapy (25%), and provision of education/counseling (13.5%) were most common. No differences were found between rankings from pharmacists in Qatar or Canada. Clinical pharmacy interventions are frequent, and those relating to alterations in drug therapy are most common. Interventions align with the perceived importance from pharmacists in both Qatar and Canada.

show abstract

Section: Introductionmentioning

confidence: 99%

Evaluation of Clinical Pharmacy Services Offered for Palliative Care Patients in Qatar

Wilby

Mohamad²,

Alyafei³

2014

Journal of Pain & Palliative Care Pharmacotherapy

View full text Add to dashboard Cite

show abstract

“…A UK study reported that more than three‐quarters of the clinical interventions made by specially trained community pharmacists in relation to prescriptions for palliative care were likely to be beneficial . The addition of community pharmacists to palliative care teams in Sweden led to improved medicines management and other team members valued answers to their queries about medicines . However, little is known about current patient–pharmacist interaction or the extent of community pharmacists' clinical roles in this area.…”

Section: Introductionmentioning

confidence: 99%

“…[13] The addition of community pharmacists to palliative care teams in Sweden led to improved medicines management and other team members valued answers to their queries about medicines. [14] However, little is known about current patient-pharmacist interaction or the extent of community pharmacists' clinical roles in this area. We wanted to explore community pharmacists' current and potential role in providing information and advice to cancer patients and their carers on the use of opioid analgesics.…”

Section: Introductionmentioning

confidence: 99%

‘Like doing a jigsaw with half the parts missing’: community pharmacists and the management of cancer pain in the community

Savage

Blenkinsopp

Closs

et al. 2012

International Journal of Pharmacy Practice

View full text Add to dashboard Cite

show abstract

“…Appropriate top‐ups corresponding with the treatment requirements of ward patients at that current time would be carried out. The introduction of pharmacists within a Swedish palliative care team was also described to be of great benefit for stock management . Participants agreed that the clinical pharmacist should also be present during the ward round.…”

Section: Discussionmentioning

confidence: 99%

Multidisciplinary views towards the clinical pharmacist: a hospital palliative cancer care team perspective in Malta

Atkins

Cunningham

2018

J Pharm Health Serv Res

View full text Add to dashboard Cite

Objectives To explore the views of the multidisciplinary healthcare team towards the role of the clinical pharmacist within the palliative care unit of an oncology hospital in Malta. At present, in Malta, clinical pharmacists are not routinely involved in care provision with palliative cancer care teams and there is a need to consider their role. Methods Three 60 min audio‐recorded heterogeneous focus groups were conducted with eligible healthcare providers at Sir Anthony Mamo Oncology Centre in Mater Dei Hospital. The topic guide was based on literature and was assessed for face and content validity by an expert panel. The transcripts were analysed using the framework method whereby emerging categories and themes were devised. Key findings A total of four doctors, ten ward nurses, two Hospice community nurses, three nursing aides, one psychologist and six allied healthcare professionals consented to participate. The framework analysis resulted in four main categories namely: (1) pharmacists as the expert reference point; (2) availability of clinical pharmacists in providing clinical services on ward level; (3) attitudes towards potential clinical services provided by clinical pharmacists; and (4) clinical pharmacists as a link with the community on pharmaceutical matters. Conclusions The general view of healthcare providers on the clinical pharmacist's role in palliative cancer care was largely supportive and positive. This should encourage policy makers to introduce clinical pharmacy services within this setting.

show abstract

Introduction of pharmaceutical expertise in a palliative care team in Sweden

Abstract: The principal result of this project is that inclusion of pharmaceutical expertise on a palliative care team can be a valuable asset for the team in pharmaceutical issues and of great benefit for stock management, including cost savings and improvement of drug logistics.

Cited by 14 publications

References 19 publications

Evaluation of Clinical Pharmacy Services Offered for Palliative Care Patients in Qatar

Evaluation of Clinical Pharmacy Services Offered for Palliative Care Patients in Qatar

‘Like doing a jigsaw with half the parts missing’: community pharmacists and the management of cancer pain in the community

Multidisciplinary views towards the clinical pharmacist: a hospital palliative cancer care team perspective in Malta

Contact Info

Product

Resources

About